vs
Side-by-side financial comparison of EXPONENT INC (EXPO) and HOPE BANCORP INC (HOPE). Click either name above to swap in a different company.
EXPONENT INC is the larger business by last-quarter revenue ($166.3M vs $141.0M, roughly 1.2× HOPE BANCORP INC). HOPE BANCORP INC runs the higher net margin — 20.9% vs 17.8%, a 3.2% gap on every dollar of revenue. On growth, HOPE BANCORP INC posted the faster year-over-year revenue change (21.0% vs 14.3%). Over the past eight quarters, HOPE BANCORP INC's revenue compounded faster (9.8% CAGR vs 8.8%).
Exponent, Inc. is an American engineering and scientific consulting firm. Exponent has a team of scientists, physicians, engineers, and business consultants which performs research and analysis in more than 90 technical disciplines. The company operates 20 offices in the United States and five offices overseas.
Bank of Hope is an American bank, based in Los Angeles, that focuses on the Korean American community. The bank was first established on December 30, 1980, under the name Wilshire Bank.
EXPO vs HOPE — Head-to-Head
Income Statement — Q1 FY2027 vs Q1 FY2026
| Metric | ||
|---|---|---|
| Revenue | $166.3M | $141.0M |
| Net Profit | $29.6M | $29.5M |
| Gross Margin | — | — |
| Operating Margin | 24.9% | — |
| Net Margin | 17.8% | 20.9% |
| Revenue YoY | 14.3% | 21.0% |
| Net Profit YoY | 11.0% | — |
| EPS (diluted) | $0.59 | $0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $166.3M | $141.0M | ||
| Q4 25 | $147.1M | $145.8M | ||
| Q3 25 | $142.0M | $141.9M | ||
| Q2 25 | $145.5M | $94.5M | ||
| Q1 25 | $136.8M | $116.5M | ||
| Q4 24 | — | $118.0M | ||
| Q3 24 | $136.3M | $116.6M | ||
| Q2 24 | $140.5M | $116.9M |
| Q1 26 | $29.6M | $29.5M | ||
| Q4 25 | $28.0M | — | ||
| Q3 25 | $26.6M | $30.8M | ||
| Q2 25 | $26.6M | $-24.8M | ||
| Q1 25 | $23.6M | $21.1M | ||
| Q4 24 | — | — | ||
| Q3 24 | $26.0M | $24.2M | ||
| Q2 24 | $29.2M | $25.3M |
| Q1 26 | 24.9% | — | ||
| Q4 25 | 19.7% | 26.8% | ||
| Q3 25 | 12.1% | 25.6% | ||
| Q2 25 | 30.5% | -27.6% | ||
| Q1 25 | 19.9% | 23.9% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | 19.0% | 27.5% | ||
| Q2 24 | 25.4% | 29.5% |
| Q1 26 | 17.8% | 20.9% | ||
| Q4 25 | 19.1% | — | ||
| Q3 25 | 18.7% | 21.7% | ||
| Q2 25 | 18.3% | -26.2% | ||
| Q1 25 | 17.2% | 18.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | 19.1% | 20.7% | ||
| Q2 24 | 20.8% | 21.6% |
| Q1 26 | $0.59 | $0.23 | ||
| Q4 25 | $0.55 | $0.27 | ||
| Q3 25 | $0.52 | $0.24 | ||
| Q2 25 | $0.52 | $-0.19 | ||
| Q1 25 | $0.45 | $0.17 | ||
| Q4 24 | — | $0.20 | ||
| Q3 24 | $0.50 | $0.20 | ||
| Q2 24 | $0.57 | $0.21 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $118.6M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $338.3M | $2.3B |
| Total Assets | $687.4M | $18.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $118.6M | — | ||
| Q4 25 | $207.4M | — | ||
| Q3 25 | $231.8M | — | ||
| Q2 25 | $245.1M | — | ||
| Q1 25 | $258.9M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $219.7M | — | ||
| Q2 24 | $203.3M | — |
| Q1 26 | $338.3M | $2.3B | ||
| Q4 25 | $402.9M | $2.3B | ||
| Q3 25 | $427.8M | $2.3B | ||
| Q2 25 | $441.4M | $2.2B | ||
| Q1 25 | $421.1M | $2.2B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | $410.3M | $2.2B | ||
| Q2 24 | $393.2M | $2.1B |
| Q1 26 | $687.4M | $18.7B | ||
| Q4 25 | $761.4M | $18.5B | ||
| Q3 25 | $759.4M | $18.5B | ||
| Q2 25 | $763.2M | $18.5B | ||
| Q1 25 | $777.3M | $17.1B | ||
| Q4 24 | — | $17.1B | ||
| Q3 24 | $744.1M | $17.4B | ||
| Q2 24 | $709.2M | $17.4B |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EXPO
| Revenues before reimbursements | $151.8M | 91% |
| Reimbursements | $14.5M | 9% |
HOPE
Segment breakdown not available.